Market revenue in 2022 | USD 2,297.4 million |
Market revenue in 2030 | USD 5,763.9 million |
Growth rate | 12.2% (CAGR from 2022 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Quality Assurance |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quality Assurance, Regulatory Affairs Services, Product Design and Development Services, Product Testing & Sterilization Services, Product Implementation Services, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device outsourcing market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 54.74% in 2022. Horizon Databook has segmented the Russia medical device outsourcing market based on quality assurance, regulatory affairs services, product design and development services, product testing & sterilization services, product implementation services, product upgrade services, product maintenance services, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Institute for Health Metrics and Evaluation, diseases such as heart disease, stroke, lung cancer, and COPD were the major causes of death in the country in 2019. The high burden of these diseases in the country is expected to boost the demand for medical devices, thus creating opportunities for medical device outsourcing providers in the country.
The Russian serialization regulations, effective as of 1st January 2020, are expected to cover all Overthe-Counter (OTC) and prescription products manufactured in or imported to Russia. As per regulations, scannable codes are required on product packaging as well as electronic reporting of all transactions across the supply chain.
These regulations are anticipated to improve the demand for outsourcing services such as regulatory affairs in the country, thus improving the competition in the Russian market. Some key players operating in the country are Takeda, Fisher Clinical Services, Marken, Les Laboratoires Servier, Parexel, and Novo Nordisk.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia medical device outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Russia medical device outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account